Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study pits two prostate surgeries Head-to-Head for better outcomes

NCT ID NCT07718256

Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This trial compares two surgical procedures—bipolar enucleation of the prostate (BEEP) and bipolar TURP (bTURP)—for treating benign prostatic hyperplasia (BPH) in men with prostates larger than 80 grams. Researchers measure how much prostate tissue remains after surgery, changes in urinary symptoms, and urine flow rate. The goal is to see which technique works better and has fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
two surgical procedures: bipolar enucleation of the prostate (BEEP) and bipolar transurethral resection of the prostate (bTURP)
What this could lead to
If BEEP proves superior, it could become the preferred surgical option for men with very enlarged prostates, offering better symptom relief and fewer complications.
What could go wrong
This is a single-center trial with 120 participants, so results may not apply to all patients. Both procedures carry risks like bleeding, infection, or urinary problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Jul 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All male patients above the age of 40 years who presented to the urology clinic in Ain Shams university hospitals with BPH with prostate size 80 - 120 g and have any of the following criteria: * Voiding symptoms that are poorly responsive to medical treatment (IPSS more than 18 and Qmax less than 15 ml/sec) * Persistent or recurrent attacks of urine retention due to BPH. * Large bladder stones from BPH. * Recurrent UTI due to BPH. * Severe gross hematuria from BPH. Exclusion Criteria: * Patients with untreated or active UTI. * Previous pelvic radiation or pelvicl trauma. * Patients with anesthesia contraindications such as uncontrolled diabetes mellitus, severe coagulation disorders and severe cardiac diseases. * Known or suspected neurogenic bladder. * Urethral stricture or urethral cancer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign prostate hypertrophy(BPH) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign prostate hypertrophy(BPH)

Contacts and locations

Locations

  • Ain Shams university hospitals

    Cairo, Cairo Governorate, 11566, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.